Free shipping on all orders over $ 500

DMAT

Cat. No. M8775

All AbMole products are for research use only, cannot be used for human consumption.

DMAT Structure
Synonym:

Casein kinase II Inhibitor; CK2 Inhibitor

Size Price Availability Quantity
5mg USD 60  USD60 In stock
10mg USD 100  USD100 In stock
25mg USD 200  USD200 In stock
50mg USD 330  USD330 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

DMAT (Ck2 Inhibitor II) is a high affinity ATP-competitive inhibitor of casein kinase II. DMAT inhibits CK2 in rat liver with 1,300-fold greater selectivity for CK2 than for CK1 (IC50 = 140 nM and >200 μM respectively). Ki = 40 nM; In Jurkat human T-cell leukemia cells, Ck2 Inhibitor II does not display side effects on mitochondria polarization at concentrations up to 10 μM. DMAT is useful for in vivo studies due to cell permeability and high efficacy in cultured cells and has implications in research of neoplasia and infective diseases, in which CK2 plays a role and is highly active constitutively.

Chemical Information
Molecular Weight 476.79
Formula C9H7Br4N3
CAS Number 749234-11-5
Solubility (25°C) DMSO 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Erik Fink Eriksen, et al. Disease-Modifying Adjunctive Therapy (DMAT) in Osteoarthritis-The Biological Effects of a Multi-Mineral Complex, LithoLexal ® Joint-A Review

[2] Hisayoshi Kondo, et al. Japan DMAT operations in the Diamond Princess cruise ship: COVID-19 medical operation

[3] Kevin K K Leung, et al. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT

[4] Akira Fuse, et al. An analysis of Japan Disaster Medical Assistance Team (J-DMAT) deployments in comparison with those of J-DMAT's counterpart in the United States (US-DMAT)

[5] Masashi Aoki, et al. Dysferlinopathy

Related Casein Kinase Products
SJ3149 

SJ3149 is a selective and potent degrader of CK1α protein in vitro and in vivo.

CK1α degrader-1 

CK1α degrader-1 is an orally active CK1α degrader with a DC50 of 0.105 μM.

ON 108600

ON 108600 is an inhibitor of CK2 (Casein Kinase2)/TNIK/DYRK1 with IC50 values of 0.016 μm/0.007 μM, 0.028 μM, 0.05 μM/0.005 μM, and 0.005 μM for DYRK1A/DYRKB, DYRK2, CK2α1/CK2α2, and TNIK, respectively. 0.005 μM. It has anti-tumor activity.

(R)-DRF053 dihydrochloride

(R)-DRF053 dihydrochloride is a potent inhibitor of casein kinase 1 (CK1), CDK1/cyclin B, and CDK5/p25, with IC50s of 14 nM, 220 nM, and 80 nM, respectively.(R)-DRF053 dihydrochloride prevented the production of CK1-dependent amyloid-β in cellular models. In addition, (R)-DRF053 dihydrochloride prevented the production of CK1-dependent amyloid-β in cell models.

Casein kinase 1δ-IN-5

Casein kinase 1δ-IN-5 is a potent and selective protein kinase CK-1δ inhibitor with an IC50 of 47 nM, which has neuroprotective and anti-inflammatory properties in vitro. It has neuroprotective and anti-inflammatory properties in vitro. It can be used in studies related to neurodegenerative diseases.

  Catalog
Abmole Inhibitor Catalog




Keywords: DMAT, Casein kinase II Inhibitor; CK2 Inhibitor supplier, Casein Kinase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.